Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,973 | 502 | 99.5% |
| Education | $41.80 | 11 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,259 | 59 | $0 (2024) |
| PFIZER INC. | $888.92 | 96 | $0 (2019) |
| Amarin Pharma Inc. | $733.87 | 49 | $0 (2020) |
| Novo Nordisk Inc | $564.90 | 51 | $0 (2019) |
| ABBVIE INC. | $395.13 | 29 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $316.32 | 15 | $0 (2022) |
| ORGANOGENESIS INC. | $312.51 | 23 | $0 (2021) |
| GlaxoSmithKline, LLC. | $294.62 | 25 | $0 (2019) |
| Amgen Inc. | $264.63 | 20 | $0 (2019) |
| Smith+Nephew, Inc. | $263.60 | 21 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $139.23 | 2 | AstraZeneca Pharmaceuticals LP ($139.23) |
| 2023 | $216.44 | 3 | AstraZeneca Pharmaceuticals LP ($216.44) |
| 2022 | $817.23 | 22 | AstraZeneca Pharmaceuticals LP ($487.42) |
| 2021 | $340.65 | 11 | AstraZeneca Pharmaceuticals LP ($228.08) |
| 2020 | $230.71 | 6 | Amarin Pharma Inc. ($78.83) |
| 2019 | $1,886 | 120 | AstraZeneca Pharmaceuticals LP ($591.31) |
| 2018 | $2,045 | 156 | AstraZeneca Pharmaceuticals LP ($297.18) |
| 2017 | $2,338 | 193 | PFIZER INC. ($387.06) |
All Payment Transactions
513 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Respiratory | ||||||
| 05/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $124.85 | General |
| Category: Respiratory | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $85.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/20/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $6.48 | General |
| Category: Respiratory | ||||||
| 05/03/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/02/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $116.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Cardio-renal | ||||||
| 10/14/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Cardio-renal | ||||||
| 08/04/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $5.16 | General |
| Category: Cardio-renal | ||||||
| 08/01/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: Cardio-renal | ||||||
| 06/24/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/25/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $101.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/24/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Respiratory | ||||||
| 05/02/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Cardio-renal | ||||||
| 05/02/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $6.35 | General |
| Category: Cardio-renal | ||||||
| 04/06/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Cardio-renal | ||||||
| 03/28/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: NEUROSCIENCE | ||||||
| 03/25/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $106.05 | General |
| Category: Cardio-renal | ||||||
| 03/16/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Cardio-renal | ||||||
| 03/16/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $6.32 | General |
| Category: Cardio-renal | ||||||
| 03/10/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 03/02/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $38.37 | General |
| Category: Respiratory | ||||||
| 02/16/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Cardio-renal | ||||||
| 02/16/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $2.49 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 435 | 699 | $92,458 | $41,312 |
| 2022 | 9 | 458 | 765 | $101,003 | $46,330 |
| 2021 | 11 | 500 | 804 | $102,226 | $47,570 |
| 2020 | 14 | 598 | 951 | $102,087 | $46,699 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 102 | 168 | $32,088 | $13,271 | 41.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 108 | 212 | $28,408 | $12,136 | 42.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 64 | 64 | $13,760 | $7,841 | 57.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 19 | 19 | $5,244 | $2,987 | 57.0% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2023 | 12 | 38 | $3,838 | $1,509 | 39.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 13 | 14 | $1,834 | $974.41 | 53.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 11 | 25 | $2,450 | $963.11 | 39.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 56 | 103 | $3,296 | $961.52 | 29.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 13 | 14 | $658.00 | $411.04 | 62.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 20 | 21 | $735.00 | $185.30 | 25.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 17 | 21 | $147.00 | $71.61 | 48.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 102 | 160 | $30,560 | $12,834 | 42.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 102 | 183 | $24,522 | $9,938 | 40.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 72 | 72 | $15,480 | $9,069 | 58.6% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2022 | 26 | 122 | $12,322 | $5,586 | 45.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 19 | 19 | $5,244 | $3,083 | 58.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 28 | 58 | $5,684 | $2,886 | 50.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 18 | 20 | $2,618 | $1,316 | 50.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 54 | 92 | $2,944 | $872.37 | 29.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 20 | 22 | $1,034 | $589.80 | 57.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 17 | 17 | $595.00 | $157.16 | 26.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 105 | 176 | $33,264 | $14,707 | 44.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 125 | 221 | $29,189 | $12,755 | 43.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 49 | 49 | $10,502 | $6,304 | 60.0% |
| 11042 | Removal of skin and tissue first 20 sq cm or less | Facility | 2021 | 26 | 88 | $8,888 | $3,934 | 44.3% |
About Dr. Daniel Fitzpatrick, D.O
Dr. Daniel Fitzpatrick, D.O is a Family Medicine healthcare provider based in Vienna, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952357758.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Fitzpatrick, D.O has received a total of $8,014 in payments from pharmaceutical and medical device companies, with $139.23 received in 2024. These payments were reported across 513 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($7,973).
As a Medicare-enrolled provider, Fitzpatrick has provided services to 1,991 Medicare beneficiaries, totaling 3,219 services with total Medicare billing of $181,911. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Vienna, OH
- Active Since 05/25/2006
- Last Updated 12/28/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1952357758
Products in Payments
- FARXIGA (Drug) $1,458
- Vascepa (Drug) $733.87
- CHANTIX (Drug) $447.92
- BREZTRI (Drug) $362.21
- Kerendia (Drug) $316.32
- ELIQUIS (Drug) $264.97
- Santyl (Drug) $263.60
- LYRICA (Drug) $228.78
- Ozempic (Drug) $221.19
- BEVESPI AEROSPHERE (Drug) $159.28
- Synthroid (Drug) $153.41
- Myrbetriq (Drug) $148.08
- TRELEGY ELLIPTA (Drug) $144.48
- SYMBICORT (Drug) $140.49
- AIRSUPRA (Drug) $139.23
- Apligraf (Device) $133.18
- BREO (Drug) $115.96
- Prolia (Biological) $114.31
- Victoza (Drug) $113.85
- Saxenda (Drug) $100.28
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Vienna
Zaid Khalil, M.d, M.D
Family Medicine — Payments: $18,527
Dr. Barbara Mackie, Md, MD
Family Medicine — Payments: $10,097
Dr. Barnett Mennen, M.d, M.D
Family Medicine — Payments: $4,521
Ernest Miller, Do, DO
Family Medicine — Payments: $4,057
Dr. Daniel Merenstein, Md, MD
Family Medicine — Payments: $3,041
Dennis Newland, Md, MD
Family Medicine — Payments: $2,955